Publications: Cancer Screening

• ASCO JCO PrecisionOncology 10:e2501142, 2026: Pragmatic, Multicenter, Double-Blind Evaluation of Circulating Cancer-Associated Macrophage-Like Cells for Detection of Cancer in Indeterminate Pulmonary Nodules

• EDRN 2025 Oral Presentation: Cancer Associated Macrophage-Like cells, A Circulating Stromal Cell Subpopulations that act as a Screening Tool for Invasive Solid Tumors and Prognosticates for Highly Aggressive Cancer Subtypes

• Polyploid Giant Cancer Cells 2024: Polyploidization of cancer associated macrophages in blood circulation acts as a blood-based biomarker for screening invasive solid tumors

• ASCO 2021: Hyper-Engorged Cancer Associated Macrophage-Like Cells in Circulation Predict for Multi-Organ Metastatic Disease in Solid Tumors

• EDRN 2021: Combining Automated Image Measurements, Blood Biomarkers, and Clinical Data for Improved Decisions in Diagnostic Mammography

• ASCO 2020: Circulating Stromal Cells as a Potential Blood Based Biomarker for Screening Invasive Solid Tumors

• EDRN 2018: Cancer Associated Macrophage-Like Cells act as a blood based biomarker for the Early detection of numerous solid tumor types

• ISMRC 2016: Cancer associated macrophage-like cells in the early detection of solid tumors

• Tri-Con 2016: Cancer associated macrophage-like cells in the early detection of solid tumors from numerous malignancies

• AACR 2015: Cancer associated macrophage-like cells as a blood-based biomarker for the screening of solid tumors